Clinical trial Recruiting at 1 site Observational Ages 18 to 99

Biobank for patients with inflammatory chronic diseases and osteoporosis

Official title: Biobank for Inflammatory Chronic Diseases and Osteoporosis of TOULouse

Run by University Hospital, Toulouse · NCT05039216 · Data updated 2026-11-12

This study is creating a biobank to collect samples from patients with chronic inflammatory diseases and osteoporosis to see if they can find markers that help doctors choose better treatments.

More Rheumatoid Arthritis trials

Quick facts

Study typeObservational
Ages18 Years to 99 Years
SexAll
Enrollment2000 (estimated)
SponsorUniversity Hospital, Toulouse
Academic / other
Locations1 site (Toulouse)
StatusRecruiting
StartedSeptember 13, 2021
Main results expectedSeptember 2, 2026
Study endsSeptember 1, 2031
Registry record updatedMarch 19, 2026
Trial IDNCT05039216 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include individuals with rheumatoid arthritis, psoriatic arthritis, spondyloarthritis, or osteoporosis who are starting a new treatment.

Probably not a fit

Patients who are pregnant, breastfeeding, unable to consent, or have severe anemia will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to create a biobank for patients at the Rheumatology center of Toulouse University Hospital who have chronic inflammatory rheumatism, such as rheumatoid arthritis, spondyloarthritis, or psoriatic arthritis, as well as those with osteoporosis. By collecting and storing biological samples from these patients, the study seeks to identify biomarkers that are associated with therapeutic responses to various treatments. This will help physicians make more informed decisions regarding treatment options based on predictive clinical and biological factors. The biobank will also focus on understanding the severity of osteoporosis and the effectiveness of anti-osteoporotic treatments.

Why it matters

Potential benefit: If successful, this study could lead to more personalized and effective treatment strategies for patients with chronic inflammatory diseases and osteoporosis.

How similar studies have gone: Other studies have shown success in identifying biomarkers for treatment responses in similar chronic inflammatory conditions, making this approach promising.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Chronic inflammatory rheumatism including RA, SpA or PsA or patients with primary or secondary osteoporosis
* With National Health Assurance
* Able to consent to the study

Exclusion Criteria:

* Pregnancy or breastfeeding
* Not able to give a consent
* Severe anemia (Hb\<10g/L)

Where it's running

  • Purpan University Hospital
    Toulouse, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.